Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CCXI | CRNX | PTCT | ||
| Company | Chemocentryx Inc | Crinetics Pharmaceuticals Inc | Ptc Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 51.98 | 52.28 | 44.77 | ||
| High | 52.00 | 54.25 | 47.42 | ||
| Low | 51.98 | 51.73 | 44.74 | ||
| Last | 51.99 | 53.60 | 46.24 | ||
| Change | +0.03 | +0.86 | +0.99 | ||
| % Change | +0.06% | +1.63% | +2.19% | ||
| Volume | 2,480,300 | 1,940,400 | 1,431,600 | ||
| 20-Day Average Volume | 1,231,860 | 760,260 | 916,160 | ||
| Previous Close | 51.96 | 52.74 | 45.25 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 51.83 | 56.15 | 47.20 | ||
| 20-Day Raw Stochastic | 97.78% | 29.24% | 30.65% | ||
| 20-Day Relative Strength | 79.02% | 45.12% | 53.19% | ||
| Weighted Alpha | +1.40 | +34.17 | +75.76 | ||
| Today's Opinion | 100% Buy | 24% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 24% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.08% since 10/12/22 | -0.11% since 12/13/24 | -0.28% since 12/13/24 | ||
| Low | 51.90 on 10/13/22 | 50.81 on 12/19/24 | 44.30 on 12/18/24 | ||
| High | 52.00 on 10/19/22 | 56.15 on 12/17/24 | 48.77 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | +0.83% since 09/19/22 | -4.41% since 11/20/24 | +10.20% since 11/20/24 | ||
| Low | 51.55 on 09/23/22 | 50.81 on 12/19/24 | 41.21 on 11/21/24 | ||
| High | 52.00 on 10/19/22 | 60.34 on 12/11/24 | 54.16 on 12/03/24 | ||
| 3-Month | |||||
| %Chg | +120.86% since 07/19/22 | +0.85% since 09/20/24 | +26.20% since 09/20/24 | ||
| Low | 21.87 on 07/25/22 | 49.13 on 09/24/24 | 34.57 on 10/07/24 | ||
| High | 52.00 on 10/19/22 | 62.53 on 11/14/24 | 54.16 on 12/03/24 | ||
| 6-Month | |||||
| %Chg | +145.24% since 04/19/22 | +21.24% since 06/20/24 | +38.90% since 06/20/24 | ||
| Low | 14.95 on 05/09/22 | 41.01 on 06/26/24 | 28.72 on 06/28/24 | ||
| High | 52.00 on 10/19/22 | 62.53 on 11/14/24 | 54.16 on 12/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,709,799 | 4,970,756 | 3,566,260 | ||
| Shares Outstanding, K | 71,356 | 92,738 | 77,125 | ||
| Annual Sales | 32,220,000 | 4,010,000 | 937,820,000 | ||
| Annual Net Income | -131,760,000 | -214,530,000 | -626,600,000 | ||
| Last Quarter Sales | 11,760,000 | 400,000 | 196,790,000 | ||
| Last Quarter Net Income | -31,650,000 | -74,050,000 | -106,650,000 | ||
| 60-Month Beta | 1.22 | 0.60 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 08/09/22 | -0.96 on 11/12/24 | -1.39 on 11/07/24 | ||
| Latest Earnings Date | 11/08/22 | 11/12/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||